ISRCTN03447252
Completed
Not Applicable
The prediction of short-term and long-term treatment response to sertraline in panic disorder
niversity Medical Center Groningen (The Netherlands)0 sites57 target enrollmentNovember 22, 2006
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity Medical Center Groningen (The Netherlands)
- Enrollment
- 57
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Panic Disorder According to Diagnostic and Statistical Manual of mental disorders (DSM\-IV)
- •2\. Two panic attacks in medication\-free run\-in period
- •3\. Outpatients more than 18 years
Exclusion Criteria
- •1\. Co\-morbid psychotic disorder, alcohol abuse, major affective disorder or personality disorder in the last year
- •2\. Participation in other drug trial 30 days prior to selection
- •3\. Serious medical illness
- •4\. History of hepatitis
- •5\. Risk of suicidality
- •6\. History of drug allergy of hypersensitivity to SSRIs
- •7\. Pregnancy, lactation or childbearing potential during the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Investigation of short-term and long-term prognosis of robot-assisted surgery for pulmonary malignancyJPRN-UMIN000040019he Division of Thoracic Surgery, the Department of Surgery, the Jikei University School of Medicine20
Completed
Not Applicable
The prediction of short-term and long-term treatment response to sertraline in panic disorder.NL-OMON21722Pfizer57
Not yet recruiting
Not Applicable
Evaluation of results in babies operated for imperforate anus- a birth defectCTRI/2020/05/025460Manipal academy of Higher education Manipal
Not yet recruiting
Not Applicable
Prospective study of short- and long-term outcomes of anatomic liver resection and local resection for hepatocellular carcinomaThe patients of HCC.JPRN-UMIN000027113Chinese PLA General Hospital, Chinese PLA Postgraduate Medical School80
Recruiting
Not Applicable
Observational Study on the long term prognosis in A Multicenter Phase II Clinical Study Evaluating the Efficacy and Safety of Neoadjuvant and Adjuvant Chemotherapy with Encorafenib, Binimetinib Plus Cetuximab in Patients with Surgically Resectable BRAF V600E Mutant Colorectal MetastasisPatients with surgically resectable BRAF V600E mutant colorectal metastasis.JPRN-UMIN000050148ational Cancer Center Hospital East44